Skip to content
Home/Companies/Biotech/eversyn

eversyn

Biotech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns eversyn?

eversyn is currently owned by bmp Ventures AG through IBG Risikokapitalfonds IV (2023 vintage), since 2025.

Hand-verified · updated 2026-07-03

bmp Ventures AG
Investor
bmp Ventures AG
IBG Risikokapitalfonds IV · 2023 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from IBG Risikokapitalfonds IV

Other portfolio companies in the same fund.

HelloTwin
Active
SaaSGermany· 2026
Litherm Technologies
Litherm Technologies
Active
IndustrialsGermany· 2026
Sedivention
Active
MedTechGermany· 2026
aevoloop
Active
IndustrialsGermany· 2025
byte robotics
Active
IndustrialsGermany· 2025
CYNiO
Active
IndustrialsGermany· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track eversyn

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy eversyn?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on eversyn.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue